Serious adverse events reported in placebo randomised controlled trials of oral naltrexone: a systematic review and meta-analysis.

BMC Med · 2019 · PMC6332608 · PMID 30642329

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginally significantno p-value reported

Secondary analysis revealed only six marginally significant adverse events for naltrexone compared to placebo, which were of mild severity.

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.